Thermo Fisher Scientific Inc. (TMO) Financials

TMO Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2026 114.2 billion 59.5 billion
June 30, 2026 113.2 billion 60.5 billion
March 31, 2026 113.3 billion 61.2 billion
Dec. 31, 2025 110.3 billion 56.8 billion

TMO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2026 2.1 billion ?
June 30, 2026 1.7 billion 82.0 million
March 31, 2026 816.0 million 83.0 million
Dec. 31, 2025 3.0 billion 84.0 million

TMO Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
Sept. 30, 2026 1.7 billion
June 30, 2026 1.7 billion
March 31, 2026 1.7 billion
Dec. 31, 2025 2.0 billion

TMO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2026 6.1 billion 39.1 billion -
June 30, 2026 4.1 billion 39.2 billion -
March 31, 2026 3.3 billion 40.1 billion -
Dec. 31, 2025 10.1 billion 35.9 billion -

TMO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2026 371.0 million
June 30, 2026 371.0 million
March 31, 2026 373.0 million
Dec. 31, 2025 377.0 million

TMO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2026 437.0 million 348.0 million 1.9 billion -
June 30, 2026 450.0 million 364.0 million 1.9 billion -
March 31, 2026 376.0 million 336.0 million 1.8 billion -
Dec. 31, 2025 465.0 million 357.0 million 2.4 billion -

TMO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2026 12.1 billion 6.9 billion
June 30, 2026 12.0 billion 7.1 billion
March 31, 2026 11.0 billion 6.5 billion
Dec. 31, 2025 12.2 billion 7.2 billion

TMO Revenue by Segment
Graph available only for paid members. Upgrade to see it.

TMO

List: Challengers

Price: $698.24

52 week price:
434.50
709.18

Dividend Yield: 0.06%

5-year range yield:
0.06%
0.44%

Forward Dividend Yield: 0.28%

Payout Ratio: 9.69%

Payout Ratio Range:
-6393.56%
562.54%

Dividend Per Share: 1.88 USD

Earnings Per Share: 18.96 USD

P/E Ratio: 36.12

Exchange: NYQ

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 1.2 million

Ebitda: 1.6 billion

Market Capitalization: 253.2 billion

Average Dividend Frequency: 4

Years Paying Dividends: 15

DGR3: 13.17%

DGR5: 14.63%

DGR10: 11.01%

Links: